• Aim of this study was to investigate the clinical outcomes of octuagenarians patients with severe aortic stenosis and intermediate-high risk treated either by means RDSV or TAVR in a multicenter evaluation. (ismics.org)
  • In this study, transapical transcatheter mitral valve-in-valve implantation (TAMVI) was compared with surgical redo mitral valve replacement (SRMVR) in terms of clinical outcomes. (frontiersin.org)
  • Clinical outcomes were based on echocardiography results. (frontiersin.org)
  • There have been a relatively small number of reports pertaining to the clinical outcomes and echocardiographic findings following TAMVI or surgical redo mitral valve replacement (SRMVR) for degenerated bioprosthetic valve or failed annuloplasty rings. (frontiersin.org)
  • Conclusions: TAVI with the CoreValve device was associated with stable clinical outcomes up to 8-year follow-up, with a low rate (2.5%) of bioprosthetic valve failure. (unipi.it)
  • Objectives: The aim of the work was to find biomarkers identifying patients at high risk of adverse clinical outcomes after TAVI and SAVR in addition to currently used predictive model (EuroSCORE). (muni.cz)
  • Results: The clinical outcomes after both TAVI and SAVR were comparable. (muni.cz)
  • To evaluate the real-world mid-term clinical and echocardiographic outcomes in patients with INSPIRIS RESILIA valve. (edwardseducation.com)
  • Preoperative clinical variables predictive of death after aortic valve replacement were determined by a stepwise logistic regression analysis in a series of 908 consecutive patients who received porcine aortic bioprostheses during a 14-year interval. (nih.gov)
  • Although it is possible that confounding factors may have played a role in the clinical outcomes of this case-control study, the study suggests that aortic valve replacement with a stentless porcine valve enhances survival. (nih.gov)
  • Differences in the properties of available TAVR systems can affect clinical outcomes. (ox.ac.uk)
  • INTERPRETATION: TAVR with the self-expanding ACURATE neo did not meet non-inferiority compared to the balloon-expandable SAPIEN 3 device in terms of early safety and clinical efficacy outcomes. (ox.ac.uk)
  • Abraham CJ, Salkini A , Burkhart H , Nakamura Y , Mir A . Spontaneous thrombus formation in native aortic root in patients with hypoplastic left heart syndrome: clinical presentation, treatment, and outcomes. (ouhsc.edu)
  • Methods We analyzed data obtained from 55 patients in a clinical trial of TAVR and from two single-center registries that included 132 patients who were undergoing either TAVR or surgical aortic-valve bioprosthesis implantation. (hofstra.edu)
  • The aim of the present investigation was to determine the incidence, risk factors for, clinical presentation of, and outcome after prosthetic valve endocarditis (PVE) in patients treated with TAVI in a nationwide study. (lu.se)
  • Herein are reported details of the authors' experience with 3VS, and their attempts to identify those factors associated with a poor clinical outcome. (johnshopkins.edu)
  • Background: Recent reports have revealed better clinical outcomes for extracorporeal cardiopulmonary resuscitation (ECPR) than conventional cardiopulmonary resuscitation (CPR).In this retrospective study, we attempted to identify predictors associated with successful weaning off extracorporeal membrane oxygenation (ECMO) support after ECPR. (authorea.com)
  • Surgical explantation of transcatheter aortic bioprostheses: Results and clinical implications. (uchicago.edu)
  • To investigate these outcomes, the researchers used data from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) trial that compared the safety and efficacy of TAVR performed with a self-expanding bioprosthesis with surgical aortic-valve replacement in patients who were deemed to be at intermediate risk for surgery. (medscape.com)
  • Nonetheless, 39% of patients had a poor outcome after TAVR. (stanford.edu)
  • Altogether, the "early favorable changes" indicated that TAVR initially worked -- and hemodynamic metrics suggested "freedom from structural valve deterioration as would be expected for mid-term follow up in bioprostheses," Douglas said at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. (medpagetoday.com)
  • OBJECTIVES: To investigate the effect of TAVR technique on in-hospital and 30-day outcomes in patients with aortic stenosis (AS) and reduced ejection fraction (EF). (omeka.net)
  • OBJECTIVES: The aim of this study was to determine the prevalence of peripheral artery disease (PAD) and its association with in-hospital outcomes after endovascular transcatheter aortic valve replacement (EV-TAVR). (omeka.net)
  • 0.001 0.81 TAVR was noninferior with respect to echocardiographic indexes of valve stenosis, functional status & quality of life Conclusion: In patients with severe aortic stenosis who are at increased surgical risk, TAVR with a self-expanding transcatheter aortic-valve bioprosthesis was associated with a significantly higher rate of survival at 1 year than surgical aortic-valve replacement. (visualmed.org)
  • Aims: Our purpose was to determine long-term outcome of high-risk patients who underwent transcatheter aortic valve implantation (TAVI) with first-generation CoreValve device defining valve durability according to the 2017 EAPCI/ESC/EACTS definitions. (unipi.it)
  • Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. (ox.ac.uk)
  • Three-year outcomes of balloon-expandable transcatheter aortic valve implantation accor ding to annular size. (wikidoc.org)
  • Two-year outcomes after transcatheter aortic valve-in-valve replacement in degenerat ed surgical valves. (wikidoc.org)
  • Outcomes among patients with heart failure with reduced ejection fraction undergoing transcatheter aortic valve replacement: Minimally invasive strategy versus conventional strategy. (omeka.net)
  • Short-term and long-term outcomes of patients undergoing urgent transcatheter aortic valve replacement under a minimalist strategy. (omeka.net)
  • Association of peripheral artery disease with in-hospital outcomes after endovascular transcatheter aortic valve replacement. (omeka.net)
  • These trends may reflect the adoption of valve-in-valve transcatheter aortic valve replacement for a degenerated bioprosthesis after its United States Food and Drug Administration approval in 2015. (aku.edu)
  • AIMS : Transcatheter aortic valve implantation (TAVI), now a common procedure to treat high-risk patients with severe aortic stenosis, has rapidly been expanding into younger and lower-risk populations, creating a need to better understand long-term outcome after TAVI. (lu.se)
  • Between 1996 and 2001, 392 patients with a mean age of 74 years underwent aortic valve replacement with stentless Freestyle bioprostheses or mechanical St Jude Medical prostheses. (bmj.com)
  • We retrospectively identified patients with degenerated mitral bioprosthesis or failed annuloplasty rings who underwent redo SRMVR or TAMVI at our medical center. (frontiersin.org)
  • The INSPIRIS RESILIA valve showed comparable early and mid-term outcomes in patients who underwent surgical aortic valve replacement (SAVR), to the Carpentier-Edwards PERIMOUNT Magna Ease valve. (edwardseducation.com)
  • To assess the potential benefits of the hemodynamic superiority of stentless valves, we conducted a case-match study among patients who underwent aortic valve replacement with two types of porcine bioprostheses: the Toronto SPV and the stented Hancock II bioprosthesis. (nih.gov)
  • We compared late results of contemporary bioprostheses and bileaflet mechanical prostheses in patients who underwent aortic valve replacement between 50 and 70 years old. (elsevierpure.com)
  • 01). Conclusion: In this study, patients aged 50 to 70 years who underwent aortic valve replacement with mechanical valves had a survival advantage relative to matched patients who received bioprostheses. (elsevierpure.com)
  • Background:This study retrospectively evaluated the long-term patient outcomes and durability of the Mosaic mitral porcine bioprosthesis in the Japan Mosaic valve long-term multicenter study.Methods and Results:The medical records of 390 patients who underwent mitral valve replacement with the Mosaic bioprosthesis at 10 centers in Japan (1999-2014) were reviewed. (ceek.jp)
  • All patients who underwent isolated reoperative SAVR for a degenerated aortic bioprosthesis between January 2012 and December 2016 were included. (aku.edu)
  • Transapical transcatheter mitral valve-in-valve implantation (TAMVI) is now regarded as a promising alternative treatment for patients with degenerated bioprosthesis or failed annuloplasty ( 3 ). (frontiersin.org)
  • Data have finally come through the VIVID Registry that assessed the durability of the bioprosthetic ViV and long-term outcomes after transcatheter implantation. (acc.org)
  • IMPORTANCE: Owing to a considerable shift toward bioprosthesis implantation rather than mechanical valves, it is expected that patients will increasingly present with degenerated bioprostheses in the next few years. (tau.ac.il)
  • logistic EuroSCORE 21.0%) allocated to TAVI transfemoral and transapical using the Edwards-Sapien valve (n = 29), or SAVR with the Edwards Perimount bioprosthesis (n = 13). (muni.cz)
  • Conclusion: We identified malondialdehyde, a marker of oxidative stress, as the most promising predictor of adverse outcomes during the 30-day and 1-year follow-up in high-risk patients with symptomatic, severe aortic stenosis treated with TAVI. (muni.cz)
  • Further, I investigated the short- and long-term outcomes of TAVI, MitraClip, and left atrial appendage closure (LAAC/Watchman) in patients with different comorbidities and risk categories (Octagenerians, cancer, CKD, and transplant recipients). (wikidoc.org)
  • The full root, stentless design of the Freestyle™ porcine bioprosthesis - based on more than 30 years of Medtronic tissue valve design improvements - can be used for full root, modified subcoronary, and complete subcoronary configurations. (medtronic.com)
  • The median (IQR) effective orifice area was 1.7 (1.4-2.0) and 1.4 (1.2-1.6) cm2at 1 and 10 years, respectively.Conclusions:The Mosaic porcine bioprosthesis offered satisfactory long-term outcomes for up to 12 years. (ceek.jp)
  • It is a great choice for younger, more active patients - and those with challenging anatomies - because of its excellent hemodynamics, durability, and patient outcomes. (medtronic.com)
  • Maximal blood flow, excellent durability and outcomes, from a valve designed to mimic nature. (medtronic.com)
  • The number of younger patients receiving aortic bioprostheses is rising, creating a need for devices with better haemodynamic performance and durability. (edwardseducation.com)
  • Objective: Improved durability of bioprostheses has led some surgeons to recommend biologic rather than mechanical prostheses for patients younger than 65 years. (elsevierpure.com)
  • Exercise hemodynamics of aortic prostheses: Comparison between stentless bioprostheses and mechanical valves. (medtronic.com)
  • On the other hand, patients receiving a stentless bioprosthesis had an increased risk of a prolonged stay in intensive care (p = 0.04) and stroke (p = 0.01) if they had severely reduced cardiac function (NYHA class IV). (bmj.com)
  • Elderly people receiving stentless bioprostheses benefit emotionally because of the avoidance of coumarin. (bmj.com)
  • However, in patients with severe hypertrophied ventricles and extraordinary calcifications, stentless bioprostheses should be chosen with caution. (bmj.com)
  • Newer generationmechanical valves have shown less PPM than older generation, and stentless bioprosthesis have less PPM than stented prosthesis.Long-termclinical outcome of PPMis associatedwith adverse cardiovascular events especially in the presence of pre-existing left ventricle dysfunction or with concomitant procedure such as coronary artery bypass graft surgery. (ochsner.org)
  • Methods: In this retrospective study, patients received either St Jude bileaflet valves or Carpentier-Edwards bioprostheses. (elsevierpure.com)
  • The Freestyle™ bioprosthesis is our most physiologic valve. (medtronic.com)
  • Endpoints included haemodynamic outcomes, survival, and incidence of structural valve deterioration (SVD). (edwardseducation.com)
  • A Cox proportional hazard model demonstrated a significant reduction in cardiac mortality rates and valve-related morbidity in patients who received the Toronto SPV bioprosthesis. (nih.gov)
  • Furthermore, patients who died or required re-interventions had mean gradients that were last recorded to be even lower than those of event-free survivors up to 3 years of follow-up, while dimensionless valve index had no relationship with outcomes, she said. (medpagetoday.com)
  • Long-term outcomes of transcatheter valve-in-valve replacement for failed aortic bioprosthesis: A meta-analysis. (wikidoc.org)
  • Survival was lower among patients with small bioprostheses and those with predominant surgical valve stenosis. (tau.ac.il)
  • Background: This study was conducted to determine the current nationwide trends and outcomes of reoperative surgical aortic valve replacement (SAVR) performed for a degenerated bioprosthesis. (aku.edu)
  • Objectives: Although primary transcatheter valve interventions have demonstrated acceptable early- and intermediate-term outcomes, data are lacking to guide patient selection for transcatheter valve-in-valve therapy. (elsevierpure.com)
  • Furthermore, very few surgical benchmarks have been established for repeat conventional biological valve replacement to refine momentum for broad application of transcatheter intervention for a degenerated bioprosthesis. (elsevierpure.com)
  • Younger age at 3VS and MV repair during the index 3VS were associated with a higher constant risk of valve reoperation, while female gender, MV prosthesis prior to index 3VS, MV replacement with a bioprosthesis during 3VS, and rheumatic TCV disease were associated with an increased late risk of valve reoperation. (johnshopkins.edu)
  • The Freestyle™ bioprosthesis is for the replacement of malfunctioning native or prosthetic aortic valves with the option of aortic root replacement. (medtronic.com)
  • Results: Four hundred forty patients were matched, and follow-up was 92% complete, with median durations of 9.1 years for patients who received mechanical valves and 6.2 years for patients who received bioprostheses. (elsevierpure.com)
  • 01). Freedoms from reoperation at 10 years were 98% for mechanical valves and 91% for bioprostheses (P = .06). (elsevierpure.com)
  • Hemorrhagic complications necessitating hospitalization occurred in 15% of patients with mechanical valves and 7% of patients with bioprostheses (P = .01). (elsevierpure.com)
  • Conclusions: The number of patients undergoing SAVR for a degenerated bioprosthesis is decreasing in the United States, particularly among older and high-risk patients. (aku.edu)
  • In this study, we sought to determine whether TAMVI could achieve outcomes on par with those of SRMVR at 3, 6, 12, and 24 months after the procedure in terms of mortality rates and echocardiographic findings. (frontiersin.org)
  • At five years, after adjustment via inverse probability of treatment weighting, the primary outcome favored the CABG group for all-cause mortality, cardiac mortality, MI, repeat revascularization and target vessel revascularization. (acc.org)
  • We reviewed the data of the isolated coronary artery bypass grafting(CABG)procedures performed in 2015 and 2016, as registered in the Japan Cardiovascular Surgery Database, for preoperative characteristics, surgical outcomes, and the choice of graft material used for the left anterior descending artery(LAD). (or.jp)
  • Patients hospitalized with influenza who also have heart failure (HF) may be at risk for worse outcomes compared with patients without HF. (omeka.net)
  • The initial data pointed out the tight bond between cardiovascular diseases and worse outcomes in COVID19-patients. (authorea.com)
  • However, there are no data on long-term outcomes after aortic ViV. (acc.org)
  • however, little is known about long-term outcomes or the safety of the minimalist strategy in this setting. (omeka.net)
  • Processed hepatic evaluating program within chronic graft-versus-host condition enhances prognostic danger stratification associated with long-term outcomes. (bcl-2protein.com)
  • Root abscess in the setting of infectious endocarditis: Short- and long-term outcomes. (uchicago.edu)
  • Cash Memorial Award: A Cleveland Clinic award established in memory of Joseph Cash, MD (Former GME chairman) for excellence in health outcomes research, presented at the Annual Education Awards Dinner, 2023. (wikidoc.org)
  • Survival was lower at eight years in patients with a small (≤20 mm) vs. large (>20 mm) failed bioprosthesis. (acc.org)
  • The objective was to determine the survival rate, the neurological outcome, and the characteristics of the survivors. (hindawi.com)
  • Survival curves and adjusted Cox proportional hazard models were used to explore the association between the type of treatment and outcomes. (scite.ai)
  • MAIN OUTCOMES AND MEASURES: Survival, stroke, and New York Heart Association functional class. (tau.ac.il)
  • These findings question recommendations of bioprostheses for younger patients and suggest that a randomized trial may be warranted. (elsevierpure.com)
  • Results: All-cause death was lower in participants submitted to percutaneous coronary intervention (PCI) (0.41, 0.16-1.03, P=0.057) compared to medical treatment (MT). Coronary-artery bypass grafting (CABG) had an overall trend for poorer outcomes: cardiovascular death 2.53 (0.42-15.10), combined cardiovascular death, nonfatal MI, and stroke 2.15 (0.73-6.31) and these events plus late revascularization (2.17, 0.86-5.49). (scite.ai)
  • Notably, 19% of patients with bioprostheses were receiving warfarin sodium at last follow-up. (elsevierpure.com)
  • Neurological complications and especially stroke are among the most important procedural outcomes from a patient's perspective, which was our motivation for this in-depth analysis of neurological outcomes in the SURTAVI trial," Durko said. (medscape.com)
  • He noted that SURTAVI has by far the best surgical outcomes seen in any of the randomized trials and that "they're unlikely to be matched, much less beaten. (medscape.com)
  • Our goal was to determine the success rate and neurological outcome of these patients and to define the characteristics of patients who might benefit from such heroic measures. (hindawi.com)
  • 6) the type of prosthesis was not an independent predictive factor of any of the outcomes tested in the multivariate analysis. (scite.ai)
  • Reduced leaflet motion was detected among patients with multiple bioprosthesis types, including transcatheter and surgical bioprostheses. (hofstra.edu)
  • CONCLUSION : The incidence of PVE was similar to that of surgical bioprostheses. (lu.se)
  • A post hoc analysis of DECISION-CTO evaluated the five-year outcomes of PCI vs. CABG in a large cohort of patients with CTO and multivessel disease. (acc.org)